Your browser doesn't support javascript.
loading
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance - authors' reply.
Gounder, P P; Mosites, E M; McMahon, B J.
Affiliation
  • Gounder PP; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
  • Mosites EM; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
  • McMahon BJ; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
Aliment Pharmacol Ther ; 45(9): 1288-1289, 2017 05.
Article in En | MEDLINE | ID: mdl-28370054
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Hepatitis B Surface Antigens Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Hepatitis B Surface Antigens Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States